Maruyama K, Kametani F, Usami M, Yamao-Harigaya W, Tanaka K
Department of Molecular Biology, Psychiatric Research Institute of Tokyo, Japan.
Biochem Biophys Res Commun. 1991 Sep 30;179(3):1670-6. doi: 10.1016/0006-291x(91)91767-7.
The major pathological change in Alzheimer's disease is the deposition of amyloid beta/A4-protein (beta P) in the brain. beta P is derived from a small part of the much larger amyloid protein precursor (APP). In the normal condition, APP is cleaved in the interior of beta P, preventing the formation of beta P, by a hypothetical proteinase "secretase". To characterize this enzyme, APP and mutated APPs were expressed by cDNA transfection in COS-1 cells, a monkey kidney fibroblast derived cell line. The mutant APPs with the mutations of the proposed cleavage site (Gln686-Lys687) were processed in the same way as wild APP. The deleted mutant APP (deletion of Arg676-Asp694) was also cleaved in a similar way to wild APP. The cleavage site of this deletion mutant was located at the 12 amino acid residues from the predicted membrane spanning domain. Hence, "secretase" cleaves APP, depending not on its specific amino acid sequence, but probably on the relative conformation with plasma membrane.
阿尔茨海默病的主要病理变化是β淀粉样蛋白/A4蛋白(βP)在大脑中的沉积。βP源自大得多的淀粉样蛋白前体(APP)的一小部分。在正常情况下,APP在βP内部被一种假想的蛋白酶“分泌酶”切割,从而防止βP的形成。为了表征这种酶,通过cDNA转染在COS-1细胞(一种源自猴肾成纤维细胞的细胞系)中表达APP和突变的APP。具有提议切割位点(Gln686-Lys687)突变的突变APP与野生APP的加工方式相同。缺失突变APP(缺失Arg676-Asp694)也以与野生APP相似的方式被切割。该缺失突变体的切割位点位于距预测跨膜结构域12个氨基酸残基处。因此,“分泌酶”切割APP,不是取决于其特定的氨基酸序列,而是可能取决于与质膜的相对构象。